Structures of langya virus fusion protein ectodomain and immunogenic compositions derived therefrom
US-2024358817-A1 · Oct 31, 2024 · US
US9435739B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9435739-B2 |
| Application number | US-201113883620-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 28, 2011 |
| Priority date | Nov 24, 2010 |
| Publication date | Sep 6, 2016 |
| Grant date | Sep 6, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compositions that comprise water, a first indicator reagent that can be converted by a first biological activity to a first biological derivative, and a plurality of particles are provided. The first indicator reagent can comprise a fluorogenic enzyme substrate having a fluorophore selected from the group consisting of umbelliferone, 7-aminocoumarin, β-naphthylamine, β-naphthol, fluorescein, resorufin, 9H-(1,3-dichloro-9,9-dimethyl acridin-2-one), rhodamine 110, a derivative of any of the foregoing fluorophores, and a combination of any of the foregoing fluorophores. The particles are capable of receiving and retaining the first biological derivative from an aqueous liquid. The first biological derivative can be indicative of a microorganism. The compositions further can comprise a gelling agent. Methods of using the compositions to detect the presence or absence of a microorganism in a sample are also provided.
Opening claim text (preview).
What is claimed is: 1. A method of detecting a biological activity, comprising: providing, a sample that may comprise a first biological activity; a first indicator reagent that can be converted by the biological activity to a first biological derivative, wherein the first indicator reagent comprises a fluorogenic enzyme substrate having a fluorophore selected from the group consisting of umbelliferone, 7-aminocoumarin, β-naphthylamine, β-naphthol, fluorescein, resorufin, 9H-(1,3-dichloro-9,9-dimethyl acridin-2-one), rhodamine 110, a derivative of any of the foregoing fluorophores, and a combination of any of the foregoing fluorophores; a plurality of particles, each particle comprising an organic polymer that receives and retains the first biological derivative, wherein the organic polymer is selected from the group consisting of acrylate polymers, polystyrene polymers, cellulosic polymers, dextran polymers, a combination of any of the foregoing and a derivative of any of the foregoing; and a gelling agent; forming a hydrogel comprising the first indicator reagent and the gelling agent; distributing the particles on at least a portion of a major surface of the hydrogel; bringing the sample into fluid communication with a portion of the hydrogel, wherein the first biological derivative partitions from hydrogel onto and/or into the plurality of particles; and detecting a presence or absence of the first biological derivative, wherein the first biological derivative is retained by a particle, wherein the presence of the first biological derivative is indicative of the presence of a first biological activity, wherein detecting the presence of the first biological derivative comprises counting a quantity of discrete fluorescent zones, and wherein the particles are between about 0.05 microns and about 20 microns. 2. The method of claim 1 , further comprising: providing a second indicator reagent that can be converted by a second biological activity to a second biological derivative; bringing the second indicator into fluid communication with the hydrogel; and detecting a presence or absence of the second biological derivative; wherein the presence of the second biological derivative is indicative of the presence of the first biological activity. 3. The method of claim 1 , further comprising: providing a second indicator reagent that can be converted by a second biological activity to a second biological derivative; bringing the second indicator into fluid communication with the hydrogel; and detecting a presence or absence of the second biological derivative.
Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence) · CPC title
Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor {(C12Q1/6897 takes precedence)} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.